PRVA — Privia Health Group Inc. price, chart and key statistics

Price data

Price

$22.93

YTD price return

-3.29%

YTD total return

-3.29%

Next earnings

Nov 5, 2026 · Before open

Market cap

2.9B2021-06 4.7B2026-10 2.9B-37.6% over the window

Enterprise value

2.6B

Shares outstanding

127.7M2019-12 95.9M2026-06 127.7M+33.2% over the window

52W low

$18.92

52W high

$28.82

From 52W high

-20.44%

From 52W low

+21.23%

52W range

41%

Volume

Rel volume

0.62×

30D volume

1.3M

30D $ vol

27.2M

Fundamentals

Sales (ttm)

2.4B2019-12 786.4M2026-06 2.4B+199.9% over the window

Sales/share

$18.462019-12 $8.202026-06 $18.46+125.2% over the window

EPS (ttm)

$0.222019-12 $0.092026-06 $0.22+139.5% over the window

FCF (ttm)

163.3M2019-12 18.6M2023-12 80.7M+332.6% over the window

FCF/share

$1.282019-12 $0.192023-12 $0.68+250.0% over the window

Book value/share

$6.122019-12 $1.122026-06 $6.12+446.8% over the window

Net margin

1.19%2019-12 1.0%2026-06 1.2%+13.8% over the window

ROE

3.59%2019-12 7.7%2026-06 3.6%-53.1% over the window

ROA

1.89%2020-12 9.5%2026-06 1.9%-80.1% over the window

Current ratio

1.622020-12 1.292026-06 1.62+24.9% over the window

Growth (CAGR, ttm) · 10Y

Sales

+24.12%2025-06-30 → 2026-06-301.9B → 2.4B (+24.1% total)+16.09%2023-06-30 → 2026-06-301.5B → 2.4B (+56.5% total)+22.35%2021-06-30 → 2026-06-30860.2M → 2.4B (+174.1% total)n/a

Net income

+89.59%2025-06-30 → 2026-06-3014.8M → 28.1M (+89.5% total)-6.13%2023-06-30 → 2026-06-3034M → 28.1M (-17.3% total)n/an/a

FCF

+71.37%2022-12-31 → 2023-12-3147.1M → 80.7M (+71.3% total)+27.97%2020-12-31 → 2023-12-3138.5M → 80.7M (+109.5% total)n/an/a

Shares

+4.08%2025-06-30 → 2026-06-30122.7M → 127.7M (+4.1% total)+2.86%2023-06-30 → 2026-06-30117.4M → 127.7M (+8.8% total)+3.85%2021-06-30 → 2026-06-30105.7M → 127.7M (+20.8% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS

+84.56%2025-06-30 → 2026-06-30$0.12 → $0.22 (+84.5% total)-8.19%2023-06-30 → 2026-06-30$0.28 → $0.22 (-22.6% total)n/an/a

Sales/share

+19.26%2025-06-30 → 2026-06-30$15.48 → $18.46 (+19.2% total)+12.86%2023-06-30 → 2026-06-30$12.84 → $18.46 (+43.8% total)+17.81%2021-06-30 → 2026-06-30$8.14 → $18.46 (+126.9% total)n/a

FCF/share

+66.21%2022-12-31 → 2023-12-31$0.41 → $0.68 (+66.1% total)+19.26%2020-12-31 → 2023-12-31$0.40 → $0.68 (+69.6% total)n/an/a

Book value/share

+10.09%2025-06-30 → 2026-06-30$5.56 → $6.12 (+10.1% total)+11.02%2023-06-30 → 2026-06-30$4.48 → $6.12 (+36.9% total)+10.49%2021-06-30 → 2026-06-30$3.72 → $6.12 (+64.7% total)n/a

Price

-13.15%2025-10-20 → 2026-10-20$26.40 → $22.93 (-13.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.10%2023-10-20 → 2026-10-20$22.86 → $22.93 (+0.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.52%2021-10-20 → 2026-10-20$24.76 → $22.93 (-7.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-13.15%2025-10-20 → 2026-10-20$26.40 → $22.93 (-13.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.10%2023-10-20 → 2026-10-20$22.86 → $22.93 (+0.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.30%2021-10-20 → 2026-10-20$24.48 → $22.93 (-6.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

106.4×2021-06 -32.012026-10 104.14-425.4% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

65.3×2021-06 -27.192026-10 65.27-340.1% over the window

Fwd P/E

21.2×

P/S (ttm)Market cap ÷ TTM revenue.

1.2×2021-06 5.452026-10 1.24-77.2% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.7×2021-06 11.932026-10 3.74-68.6% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

17.9×2021-06 127.742026-10 36.31-71.6% over the window

EV/EBITDA (fy)

45.3×

EV/Sales (ttm)

1.1×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

5.58%2021-03 0.9%2023-12 3.0%+222.8% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 127.7M ÷ 122.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-4.08%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-4.08%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-4.08%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2021-03 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2.9B). Same caveat as the cash buyback yield.

0.00%2021-03 0.0%2026-06 0.0%

Vs own 10Y history

P/E

22nd

P/OI

6th

P/S

9th

P/B

15th

P/FCF

41st